Skip to content

    Diabetes Health Center

    Font Size
    A
    A
    A

    Recall of Defective Glucose Test Strips

    FDA Says Faulty Strips Could Give Diabetes Patients Inaccurate Reading of Glucose Levels
    By
    WebMD Health News
    Reviewed by Laura J. Martin, MD

    Dec. 22, 2010 -- The FDA says it is working with Abbott Diabetes Care to recall 359 million defective glucose test strips -- sold under a variety of brand names -- that may make blood glucose levels look lower than they really are.

    The FDA says the defective strips “can lead users to try to raise their blood glucose when it is unnecessary or to fail to treat elevated blood glucose due to a falsely low reading,” and that “both scenarios pose health risks.”

    About 24 million Americans have diabetes.

    Abbott says the defective strips aren’t absorbing enough blood to provide an accurate reading. The company also says test strips stored for a long time in medicine cabinets or test strips that have been exposed to warm temperatures could give false results.

    “FDA and Abbott are reviewing the cause of the manufacturing defect to avoid this problem in the future,” Alberto Gutierrez, PhD, of FDA’s Center for Devices and Radiological Health, says in a news release.

    Gutierrez says diabetes patients “should be aware of the recalled glucose test strips and take steps to prevent them from affecting their health.”

    Which Strips Are Being Recalled

    The strips being recalled are used with Abbott’s MediSense Optium, Precision Xceed Pro, Precision Xtra, Optium, Optium EZ, and ReliOn Ultima blood glucose monitoring systems.

    The lots were manufactured between January and May of this year and sold in retail stores in the U.S. and Puerto Rico. The strips are used both by consumers and health care professionals.

    Abbott says the strips should not be used and will be replaced at no cost to consumers.

    It says the monitoring systems themselves are not being recalled, just the defective strips.

    Patients should contact their health care providers to determine testing options if they don’t have any unaffected test strips to use.

    The FDA says it is working with Abbott to avoid any potential shortages of useable products. The company says it will take about eight weeks to produce and distribute enough strips to replace all the defective ones that have been distributed.

    1 | 2 | 3

    Today on WebMD

    Diabetic tools
    Symptoms, diagnosis, treatment, and more.
    woman flexing muscles
    10 strength training exercises.
     
    Blood sugar test
    12 practical tips.
    Tom Hanks
    Stars living with type 1 or type 2.
     
    kenneth fujioka, md
    Video
    Can Vinegar Treat Diabetes
    Article
     
    Middle aged person
    Tool
    jennie brand miller
    Video
     

    Prediabetes How to Prevent Type 2 Diabetes
    Article
    type 2 diabetes
    Slideshow
     
    food fitness planner
    Tool
    feet
    Slideshow